Healthcare enterprise Centene (NYSE:CNC) said on Tuesday that the 2015 earnings per diluted share, excluding Health Net merger related costs, is expected to exceed its prior range of USD2.90 to USD2.94.
The company recorded total revenues of USD22.8bn and diluted earnings per share (EPS) of USD2.89 in 2015.
For its 2016 fiscal year, the company expects total revenues in the range of USD41.2bn to USD42.0bn; GAAP earnings per diluted share of approximately USD2.85 to USD3.15; As well as adjusted earnings per diluted share of approximately USD4.10 to USD4.40.
In conjunction, the company will disclose its full 2015 fourth quarter and year-end financial results at 6:00 (Eastern Time) on 9 February 2016.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development